Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer.
Journal: Biomark Med
Date: 2016 Nov
Major Program(s) or Research Group(s): CBRG
PubMed ID: 27673558
PMC ID: PMC5493967
Abstract: Given the low incidence of pancreatic cancer in the general population, screening of pancreatic cancer in the general population using invasive modalities is not feasible. Combination of invasive screening with noninvasive biomarkers for pancreatic cancer and its precancerous lesions has the potential to reduce mortality due to pancreatic cancer. In this review, we focus on biomarkers found in the blood that can indicate early-stage pancreatic cancer, and we discuss current strategies for screening for pancreatic cancer. We recently identified a unique alteration in apolipoprotein A2 isoforms in pancreatic cancer and its precancerous lesions, and we describe its clinical usefulness as a potential biomarker for the early detection and risk stratification of pancreatic cancer.